SHENZHEN, China, Jan. 9, 2012 /PR Newswire-Asia/ -- Global Pharm
Holdings Group, Inc. (OTCBB: GPHG) ("Global Pharm" or the
"Company"), a growing vertically integrated pharmaceutical company
engaged in the distribution of pharmaceutical-related products,
Traditional Chinese Medicine ("TCM") processing, and herbal
cultivation and sales in China
through its subsidiaries in Anhui,
Jilin, Guangdong and Shandong provinces, today announced the
appointment of Mr. Kwong Chi Wong
(Simon) as a non-executive director to its Board of Directors (the
"Board"), effective January 4, 2012.
The Board increased the size of the Board from five to six
directors on January 4, 2012 and
appointed Mr. Wong to fill the vacancy. Currently, three of
the Board members are independent directors, one is a non-executive
director and two are executive directors.
Mr. Wong brings more than three decades of experience in
investing and assisting companies in China. Since March 5,
2010, Mr. Wong has been executive director and chief
executive officer of China.com Inc. (HKEX 8006). Mr. Wong served as
a director of CDC Corporation, the ultimate holding company of
China.com Inc., until September 2011.
Mr. Wong is also a director and chief executive officer of CDC
Games Corporation and a director of CDC Games International
Corporation, both of which are subsidiaries of CDC Corporation.
Mr. Wong was a managing partner of Asian Global Capital ("AGC").
Prior to joining AGC, he was a director and executive vice
president of Transpac Capital Ltd. ("Transpac"), one of the
earliest and largest private equity investment firms in
Asia, managing a $820 million portfolio with investments in
approximately 200 companies in East
Asia and the United States.
Prior to joining Transpac, Mr. Wong was deputy managing director of
Cony Electronics Products Ltd. and Hung Nien Electronics Ltd. in
Hong Kong and president of Cony
Electronics Inc. in Chicago. Mr.
Wong also serves on the boards of various Hong Kong listed companies and holds
leadership positions in various Hong
Kong financial and industrial associations and councils. Mr.
Wong received Bachelor of Science and MBA degrees from the
Chinese University of Hong Kong.
"We are excited to add Mr. Kwong Chi
Wong (Simon) to our newly enhanced board," said Mr.
Yunlu Yin, Chairman and Chief
Executive Officer of Global Pharm. "Simon's comprehensive
understanding of the financial markets and extensive experience of
investment and operational management in numerous companies add a
distinctive knowledge base and comprehensive business network to
our board. The expansion of Global Pharm's Board of Directors
ensures that the company will continue to benefit from a diversity
of experience and opinions."
About Global Pharm
Global Pharm Holdings Group, Inc., a growing integrated
pharmaceutical company, is engaged in the distribution of
pharmaceutical-related products, Traditional Chinese Medicine (TCM)
processing, and herbal cultivation and sales in China. The Company focuses on building
regional distribution channels, as well as a local capillary sales
network with a high-margin product portfolio. Currently, its sales
network covers Shandong,
Jilin, Anhui and Guangdong provinces. Global Pharm seeks to
establish an integrated value chain in the pharmaceutical industry
through strategic acquisitions within the TCM production,
pharmaceutical distribution and retail sectors. For further
information, please visit the Company's corporate website at
http://www.globalpharmholdings.com.
Forward-looking Statements
Certain statements set forth in this press release contain or
may contain forward-looking statements and information that are
based upon beliefs of, and information currently available to, our
management as well as estimates and assumptions made by our
management. Such statements reflect the current view of our
management with respect to future events and are subject to risks,
uncertainties, assumptions and other factors as they relate to our
industry, our operations and results of operations, plans for
future facilities, capital-expenditure plans and any businesses
that we may acquire. Although we believe that the expectations
reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance or
achievements. Except as required by applicable law, including the
U.S. federal securities laws, we do not intend to update any of the
forward-looking statements to conform them to actual results.
For Additional Information Contact
Global Pharm Holdings Group, Inc.
Ms. Susan Liu
Phone: +86-755-3693-9373
Email: susanliu@globalpharmholdings.com
SOURCE Global Pharm Holdings Group, Inc.